Awareness of Non-Alcoholic Steatohepatitis and Treatment Guidelines: Progress and Implications for Clinical Research

Time: 10:00 am
day: Day Two


• Exploring the substantial gaps in knowledge and awareness of testing modalities to facilitate the identification of patients with non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH)
• Understanding the urgent need to efficiently identify patients to facilitate successful clinical trial enrolment
• Explaining our randomised online survey of primary care physicians (PCPs), gastroenterology and endocrine specialists to assess physician awareness and adoption of testing options to identify NAFLD and NASH patients and optimise patient care